Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...

FILE - A Merck scientist conducts research on Feb. 28, 2013, in West Point, Pa. Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...

FILE - A Merck scientist conducts research on Feb. 28, 2013, in West Point, Pa. (AP Photo/Matt Rourke, File) (Matt Rourke, Copyright 2017 The Associated Press. All ...

For the recently completed fourth quarter, Merck booked an adjusted profit of $1.72 per share on $15.6 billion in revenue. Sales of top-selling cancer treatment Keytruda climbed 19% to $7.84 billion.

Merck 2025 Sales Forecast Underwhelms as It Pauses Gardasil Sales in China Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due ...